PDL BioPharma buys share of Cerdelga royalties

11-11-2014

Healthcare company PDL BioPharma has announced that it will soon gain royalties from sales of Sanofi’s Cerdelga (eliglustat) drug, used to treat Gaucher disease.


PDL BioPharma, Cerdelga, Sanofi, Genzyme, University of Michigan

LSIPR